AI in drug discovery: A wake-up call.
AI in drug discovery: A wake-up call.
复制标题
药物发现中的人工智能：敲响警钟。
DOI：
10.1016/j.drudis.2022.103410
复制
发表时间：
2023
影响因子：
7.4
通讯作者：
Ekins,Sean
中科院分区：
文献类型：
--
作者：
Urbina,Fabio;Lentzos,Filippa;Invernizzi,Cédric;Ekins,Sean
在 Collaborations Pharmaceuticals Inc. 向瑞士联邦 NBC 保护研究所进行了关于药物发现中的两用人工智能 (AI) 的概念验证演示后，我们在极具影响力的《自然机器智能》评论中探讨了生成算法如何开发神经毒剂 VX 和数以万计的类似物。我们不仅布置了实验，而且在军备控制和军民两用专家的指导下，我们呼吁就人工智能在药物发现中的一般重新利用潜力进行更多讨论。为了继续这一对话，我们现在分享有关该实验的更多细节，并将我们的经验置于其他科学家的更大框架中，这些科学家也开发了类似的强大技术，但没有参与，甚至没有真正理解这些技术的滥用潜力和下游后果。我们真诚地希望我们的实验能够为生成人工智能的用户敲响重要的警钟。
Following a proof-of-concept presentation on dual-use artificial intelligence (AI) in drug discovery by Collaborations Pharmaceuticals Inc. to the Swiss Federal Institute for NBC-Protection, we explored how a generative algorithm could develop the nerve agent VX and tens of thousands of analogs in a highly impactful Nature Machine Intelligence commentary. We not only laid out the experiment, but, with guidance from experts on arms control and dual-use, we called for more discussion around the general repurposing potential of AI in drug discovery. To continue that conversation, we now share further details on the experiment and place our experiences in the larger frame of other scientists who have similarly developed powerful technologies but without engaging with, or even truly understanding, the misuse potential and downstream consequences of the technologies. It is our sincere hope that our experiment may serve as an important wake-up call for users of generative AI.